Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Roivant Sciences

https://roivant.com/

Latest From Roivant Sciences

Stock Watch: Poxel Passes Go…But To Where?

Poxel’s shift to new therapeutic areas may be necessary despite Japan’s approval for its diabetes drug. Twymeeg looks set to be hamstrung by placebo-controlled studies without outcomes data.

Approvals Commercial

KRAS Inhibitors Show Promise But Long Road Ahead, Say Experts

Harvard Medical School’s Dr. Bruce Chabner, Bayer Pharma’s global head of research and Roivant Sciences founder, among others, share their views on the challenges and path ahead for KRAS inhibitors and other oncology modalities including CAR-T therapy.

Cancer Research & Development

IPO Update: Booming Biopharma On Pace For Another Record Year

Only 25 more initial public offerings are needed for 2021 to beat 2020’s record-breaking 86 IPOs. However, the average return for this year’s offerings is just 1.1% as of 1 July versus 11% at the end of the first quarter.

Financing Business Strategies

Latest Japan Approvals Include Evrysdi For SMA

Japan's latest batch of product approvals includes the country's second therapy for SMA and the first nod globally for a novel antidiabetic.

Japan Approvals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Altavant Sciences
    • Alyvant
    • Aruvant Sciences
    • Axovant Sciences
    • Cyotvant Sciences
    • Datavant
    • Dermavant Sciences
    • Enzyvant
    • Genevant
    • Immunovant Sciences
    • Metavant Sciences
    • PhaseRx
    • Respivant
    • Roivant Health
    • Roivant Neurosciences Ltd
    • Roivant Pharma
    • Roivant Sciences Ltd.
    • Inc.
    • Sinovant Sciences
    • Sumitovant Biopharma Ltd.
    • Valor Biotechnology
    • Axovant Gene Therapies Ltd.
UsernamePublicRestriction

Register